In the spring of 2012, a routine internal audit at the William A. Hinton State Laboratory Institute in Jamaica Plain, Massachusetts, turned up a set of numbers that defied easy explanation. A mid-level chemist named Annie Dookhan had been logging drug sample analyses at a rate no human being could plausibly sustain. While her colleagues processed between 50 and 150 samples per month — the industry standard for careful, defensible forensic work — Dookhan was routinely certifying 500 or more. Her supervisors had noticed the numbers before. They had praised her for her exceptional productivity. They had given her awards. They had called her a model employee.

What they had actually done was let her run unchecked for nearly a decade while she fabricated test results, contaminated evidence samples, forged her supervisor's signature on official state documents, and helped imprison thousands of Massachusetts residents on the basis of drug analyses that were, in many cases, entirely invented. She never actually tested the samples. She just wrote down that she had.

By the time the full scope of Annie Dookhan's fraud became clear, approximately 24,000 drug samples she had handled were in question — and more than 40,000 defendants had criminal convictions tied to her work. In 2018, the Massachusetts Supreme Judicial Court ordered the mass dismissal of roughly 21,587 cases in a single ruling, one of the largest vacatings of criminal convictions in American legal history. The state, by that point, had spent six years fighting to keep many of those people imprisoned anyway.

But Dookhan was not the worst of it. As state officials scrambled to contain the damage from the Hinton Lab catastrophe, a second forensic chemist at a different Massachusetts state lab — a woman named Sonja Farak — was simultaneously collapsing under investigation. Farak had been using the very drug evidence she was supposed to test: smoking crack cocaine on the job, consuming methamphetamine, ingesting ketamine, stealing samples directly from the state evidence room. She had been doing it, investigators would eventually determine, since at least 2004. The Massachusetts Attorney General's office — first under Martha Coakley, then under Maura Healey — knew the full extent of Farak's addiction early. They hid it from defense attorneys for years. In 2017, the state's highest court used the phrase "egregious misconduct" to describe what the AG's office had done.

This is not a story about two bad actors. It is a story about an entire system — forensic laboratories run without meaningful oversight, supervisors who had every incentive not to ask hard questions, prosecutors who profited from fraudulent results and deliberately avoided scrutiny, and an Attorney General's office that, when confronted with the truth, chose cover-up over accountability. It is a story that never received the national outrage it deserved. And its lessons, still largely ignored, continue to put innocent people behind bars across the country today.

A System Built on Trust Without Verification

To understand how Annie Dookhan could fabricate drug test results for nearly a decade without detection, you have to understand how Massachusetts' drug lab system was structured — and why it was structurally incapable of catching her.

Forensic drug analysis in Massachusetts, as in most states, existed at the intersection of criminal justice and public health bureaucracy. The Hinton Laboratory was a state facility, funded by the Massachusetts Department of Public Health, staffed by civil servants, and tasked with processing drug evidence submitted by law enforcement agencies across the commonwealth. Its chemists were the invisible backbone of the drug prosecution machine: without their signed certificates of analysis, prosecutors could not prove that a white powder was cocaine, a green herb was marijuana, or a pill was heroin. The certificates were, in effect, the scientific imprimatur that transformed a police officer's accusation into a provable criminal fact.

The laboratory operated under a model of professional trust that would have been recognizable to anyone familiar with the broader culture of forensic science: analysts were assumed to be honest, their methods were assumed to be sound, and the volume of their output was taken as evidence of their diligence rather than cause for suspicion. Peer review — in the sense of having another chemist independently verify results — was minimal to nonexistent for routine cases. Quality assurance protocols were lax. Supervision was largely administrative rather than scientific. Nobody was watching the work.

This was not unique to Massachusetts. A landmark 2009 report from the National Academy of Sciences, Strengthening Forensic Science in the United States: A Path Forward, found that forensic laboratories across the country suffered from insufficient oversight, inadequate standards, and a troubling tendency to function as arms of the prosecution rather than as independent scientific institutions. The report warned, presciently, that the institutional incentives in forensic science pointed toward conviction rather than truth. In Massachusetts, those warnings went unheeded.

Into this environment stepped Annie Dookhan — ambitious, eager to please, and apparently willing to do whatever it took to produce the results that kept prosecutors happy and supervisors off her back.

Annie Dookhan: Star Chemist, Serial Fraudster

Annie Dookhan joined the Hinton Laboratory in 2003. She was, by all outward appearances, the kind of employee a beleaguered state agency dreams of: cheerful, enthusiastic, extraordinarily productive. Where other chemists worked at a steady pace, Dookhan worked at a sprint. Where colleagues completed their paperwork promptly, Dookhan completed hers before anyone else. She answered emails from prosecutors late at night. She offered to take on extra samples when colleagues fell behind. She expressed, vocally and often, her deep commitment to justice and to the mission of the lab.

She was lying about nearly all of it.

Dookhan had also fabricated her academic credentials. She told colleagues and supervisors she held a master's degree in chemistry from the University of Massachusetts Boston. She did not. She had taken some coursework but never completed the degree. The lie went unchecked for years. No one verified her credentials in any systematic way. In the informal culture of the lab, her performance — her extraordinary, implausible performance — seemed to speak for itself.

She also cultivated an unusual relationship with at least one prosecutor. Emails later obtained by investigators showed Dookhan had developed a close, personal correspondence with George Papachristos, an assistant district attorney in Suffolk County. The relationship appeared to cross appropriate professional boundaries, with Dookhan expressing concern for case outcomes, offering to help ensure specific results, and functioning less as an independent scientist and more as an ally invested in the prosecution's success. Papachristos later faced ethics scrutiny for his role in the correspondence. The emails were, in retrospect, a window into the deeper pathology of Dookhan's fraud: she had internalized a prosecutorial worldview in which the purpose of her work was to secure convictions, not to find truth.

Her supervisors, meanwhile, had access to her output numbers. They knew she was processing samples at roughly three to ten times the rate of her colleagues. At various points, they flagged the discrepancy and asked questions. Her answers were always satisfying: she was efficient, she worked hard, she had developed her own methods. The supervisors accepted these explanations. They gave her a career achievement award. They held her up as a model for other chemists. In a functioning oversight system, an analyst processing 500 samples per month while colleagues processed 100 would have triggered an immediate audit. In Massachusetts, it triggered a commendation.

The Mechanics of Fraud: Dry-Labbing, Sample Mixing, and Forgery

The term forensic scientists use for what Dookhan did is "dry-labbing" — reporting test results without actually conducting the tests. It is the forensic equivalent of a doctor signing a death certificate without examining the body. You write down a number, a conclusion, a finding, and you certify its accuracy with your professional signature. The work is never done. The result is entirely fabricated.

Dry-labbing was the most pervasive of Dookhan's frauds, but it was not the only one. Investigators determined she had also engaged in deliberate sample contamination — the practice of mixing samples from known drug cases with evidence from other cases to ensure positive results. If a sample was ambiguous or might test negative, she could mix it with a confirmed drug sample and certify the combined result as positive. The defendant, reviewing only the final certificate of analysis, would have no way to know the test had been manipulated.

She also forged the signature of her supervisor, Daniel Young, on official laboratory documents — a direct, unambiguous act of fraud that speaks to both her audacity and to the absence of meaningful verification in the system. Young's signature was required on certain documents as a supervisory check. Dookhan simply wrote it herself when it was inconvenient to seek it. Young, for his part, did not notice — or did not inquire — for years.

The full scope of which samples were legitimately tested and which were fabricated may never be known. Dookhan processed approximately 60,000 samples during her tenure at Hinton. Of those, investigators were able to confirm that roughly 24,000 were "tainted" in ways that could not be reliably disentangled from legitimate results. The rest existed in an epistemic fog — they might have been accurately tested, or they might not. Defense attorneys, prosecutors, and courts were left trying to sort through a decade of compromised science with no reliable map.

For defendants whose convictions rested on Dookhan's certificates, this uncertainty was not abstract. Many of them had already served their sentences. Many had pled guilty under pressure — a common dynamic in drug cases, where the stakes of going to trial are severe and the path of least resistance is to accept a deal. Their pleas had been predicated on the assumption that the evidence against them was real. In many cases, it was not.

The Moment the Lie Finally Collapsed

In late June 2012, Dookhan attempted to check drug evidence out of Hinton's evidence room without following proper procedures. A colleague noticed the irregularity and reported it. When supervisors confronted Dookhan, she initially offered explanations. When those explanations failed to hold, she confessed to a portion of her misconduct. She admitted to "dry-labbing" — to signing off on results without conducting tests — but she minimized the scope of what she had done. She framed it as a lapse rather than a systematic fraud.

She resigned in August 2012. The laboratory was shut down. The Massachusetts Department of Public Health notified the state's district attorneys that there was a potential problem with cases involving Dookhan's analyses. And then, for months, the criminal justice system confronted the question of what to do about the tens of thousands of defendants whose convictions now rested on tainted evidence.

The early response from prosecutors was revealing. Rather than treating the discovery as an emergency requiring urgent review of potentially unjust convictions, many prosecutorial offices treated it as a damage-control problem. The instinct was not to identify who had been wrongly imprisoned and act quickly to remedy it. The instinct was to figure out how many convictions could be preserved.

Dookhan was arrested by state police in November 2012. She was charged with 27 counts including obstruction of justice, evidence tampering with intent to deceive, and perjury. She pled guilty to all 27 counts in November 2013. At sentencing, she offered a tearful apology. Superior Court Judge Carol Ball sentenced her to 3 to 5 years in state prison. She was released after serving approximately two years.

"Power always thinks it has a great soul and vast views beyond the comprehension of the weak; and that it is doing God's service when it is violating all His laws."

The Catastrophic Scale: 40,000 Defendants and Six Years of Resistance

After Dookhan's arrest, Massachusetts faced a problem with no clear precedent. How do you administer justice for 40,000 people whose convictions are built on fraudulent science?

The state's initial approach was to create a notification system: defendants with Dookhan-related convictions would be notified that they might be entitled to a new trial or other relief, and they could seek it through the courts. This approach placed the entire burden of action on defendants — many of whom had already served their time, had no lawyers, had limited English proficiency, lacked resources to navigate the court system, or were too frightened of the consequences of re-engaging with the criminal justice system that had already harmed them.

Public defenders and defense advocacy organizations quickly recognized that the notification model was inadequate. They argued that the state had an affirmative obligation to proactively vacate convictions tainted by fraud, rather than requiring each defendant to individually seek relief. The state resisted this position strenuously. The District Attorneys' offices — whose prosecutorial reputations were intertwined with the validity of thousands of Dookhan-certified convictions — argued that many defendants had voluntarily pled guilty and could not now claim their pleas were involuntary simply because some of the evidence had been compromised.

This argument required a kind of epistemic bad faith that should have embarrassed anyone who made it in a courtroom. The entire foundation of a knowing, voluntary guilty plea is that the defendant understands the evidence against them and makes a calculated decision based on that understanding. When the evidence is fabricated, the plea is not knowing. It is coerced by fraud. But prosecutors pressed the argument anyway, and courts were slow to reject it.

The litigation dragged on for years. Defense attorneys filed tens of thousands of individual motions. Courts processed them one at a time. Defendants who had been released from prison returned to court. Defendants who had moved on with their lives — found jobs, rebuilt families, tried to forget — were forced to return to a system that had already wronged them once. The state, with its unlimited resources, dragged out the proceedings while individual defendants with limited resources struggled to keep up.

It took until 2017 and 2018 for the Massachusetts Supreme Judicial Court to finally act decisively. In Bridgeman v. District Attorney for the Suffolk District, issued in January 2017, the SJC established a framework for handling Dookhan defendants. In a follow-up ruling in 2018, the court ordered the dismissal of approximately 21,587 cases in which defendants had pled guilty and the only evidence tying them to the charged drugs was Dookhan's certificate of analysis. This was, by any measure, an extraordinary act of judicial housekeeping — and a tacit acknowledgment that the state had failed, for six years, to do what justice required.

Some of those 21,587 defendants were, in all likelihood, guilty of the drug offenses charged. Some were not. The court's ruling acknowledged what should have been obvious from the beginning: that when the state's evidence is fraudulent, the state forfeits its right to maintain the convictions that evidence produced. The integrity of the system depends on that principle. Without it, there is no system — only organized coercion dressed in the language of law.

Sonja Farak: The Second Scandal — Worse Than the First

While the Dookhan catastrophe was still unfolding, Massachusetts officials discovered they had a second forensic fraud crisis on their hands — one that was, in certain respects, even more disturbing.

Sonja Farak had worked as a chemist at the Amherst State Police Crime Lab since 2004. The Amherst lab was a separate facility from Hinton, serving western Massachusetts. Like Dookhan, Farak had been responsible for certifying the chemical identity of drug evidence submitted by law enforcement. Unlike Dookhan, who falsified results to appear productive, Farak had a different problem: she was addicted to the substances she was supposed to be testing.

Investigators determined that Farak had begun stealing and using drug evidence from the Amherst lab's reference standards and evidence inventory as early as 2004. She consumed crack cocaine, methamphetamine, ketamine, MDMA, and other controlled substances while on duty, often in the lab itself. She maintained personal notebooks documenting her drug use and her efforts to conceal it. She fabricated lab results while intoxicated. She stole evidence that had been submitted by law enforcement for testing. She did this, apparently, for approximately nine years.

She was arrested on January 18, 2013 — just months after Dookhan's arrest — after a colleague noticed that drug standards in the evidence room appeared to have been tampered with. Farak eventually pled guilty to evidence tampering and other charges and was sentenced to 18 months in jail.

The criminal case against Farak was straightforward. What came next was not.

When investigators from the Attorney General's office searched Farak's home and workspace, they found evidence — including personal notebooks and therapy records — that made clear she had been using drugs since at least 2004. This evidence was material to defense attorneys seeking to vacate their clients' convictions, because the scope of the taint depended directly on how long Farak had been impaired on the job. If she had only begun using in 2011 or 2012, as the AG's office initially represented to courts, then only cases from those years were affected. If she had been using since 2004, then nearly a decade of Amherst lab results were potentially compromised — thousands upon thousands of additional cases.

The AG's office received Farak's personal notebook in the summer of 2013. The notebook made clear she had been using drugs for years before 2011. The AG's office did not disclose it.

The Cover-Up: How Massachusetts Hid the Truth

The suppression of Farak's notebook was not a passive oversight. It was an active decision. Prosecutors in the AG's office reviewed the evidence, understood its significance, and chose not to turn it over to defense attorneys who were actively litigating cases on behalf of defendants whose convictions were potentially tainted by Farak's drug use.

This decision had a direct legal consequence: it meant that courts adjudicating requests for new trials from Farak defendants were operating on incomplete and misleading information. The AG's office had told courts that Farak's drug use was a recent phenomenon. The notebook showed it was not. Defendants who might have been entitled to relief based on the true timeline of Farak's impairment were denied that relief because the state withheld the evidence that would have established it.

The concealment persisted through a change in administration. Martha Coakley served as Massachusetts Attorney General until January 2015. Maura Healey — who would later be elected Governor in 2022 — succeeded her. Healey's office continued to withhold the relevant materials from defense attorneys. The full picture did not emerge until 2016, when defense attorneys in post-conviction proceedings independently pieced together the evidence and confronted the state with what it had been hiding.

The response from the AG's office, even then, was grudging. Officials acknowledged that the Farak notebook had been in their possession for years. They did not acknowledge any wrongdoing. They offered explanations that defense attorneys and the court ultimately found inadequate and unconvincing.

In January 2017, the Massachusetts Supreme Judicial Court issued its ruling in Bridgeman v. District Attorney — a decision that addressed both the Dookhan and Farak situations. On the Farak question, the court was unsparing. It found that the AG's office had committed "egregious misconduct" by withholding evidence of Farak's long-term drug use. It found that this misconduct had infected the proceedings in which defendants sought post-conviction relief. And it found that the appropriate remedy was to presume that all cases touched by Farak's work were tainted — shifting the burden to the state to prove that any given conviction was untainted, rather than requiring each defendant to prove they had been harmed.

In practical terms, this meant that all approximately 8,000-plus cases associated with Farak's work at the Amherst lab were subject to dismissal. Many were subsequently vacated.

"The time to guard against corruption and tyranny is before they shall have gotten hold of us. It is better to keep the wolf out of the fold than to trust to drawing his teeth and talons after he shall have entered."

The Human Toll: Lives the Statistics Don't Capture

When journalists and legal scholars write about the Massachusetts drug lab scandal, they speak in round numbers: 40,000 cases, 21,000 dismissals, 8,000 Farak cases. These are staggering figures. They are also abstractions that make it easy to lose sight of what they actually represent.

Behind each of those numbers is a person who was charged, prosecuted, and in many cases convicted based on fraudulent science. Many of them pled guilty to offenses that may never have been proven had an honest chemist tested their samples. Many accepted plea deals that included jail time, probation, mandatory drug treatment, and permanent criminal records — collateral consequences that follow a person for life, affecting their ability to find employment, housing, educational opportunities, and professional licenses.

Consider what it means to have a drug conviction on your record in America. In Massachusetts, as in most states, a drug conviction can result in loss of eligibility for federal student loans, loss of public housing, disqualification from certain professional licenses, immigration consequences for non-citizens including deportation, and disenfranchisement. These are not consequences that disappear when a conviction is vacated. The years in which the conviction was on your record — years during which you were denied housing, denied a loan, denied a job — do not come back. The relationships strained or destroyed by an incarceration, even a brief one, do not automatically repair themselves.

Advocates who worked on behalf of Dookhan and Farak defendants described meeting clients who did not understand they had a claim for relief. Who had moved on and were afraid that engaging with the courts again would make things worse. Who had been told so many times that the system was trustworthy that they had internalized a sense of personal responsibility for convictions that were, in fact, the product of someone else's fraud. The damage of the Massachusetts drug lab scandal is not fully captured by the number of vacated convictions. It lives in the texture of tens of thousands of lives disrupted, derailed, and diminished by a state that failed them at every turn.

Accountability That Never Came

Annie Dookhan served approximately two years in prison for a fraud that contaminated 40,000 criminal cases and compromised the integrity of Massachusetts' criminal justice system for a generation. She was released in 2016. She now lives privately, largely out of public view.

No prosecutor who used Dookhan's fraudulent certificates to convict defendants was ever charged with a crime. No supervisor who received warnings about her output and ignored them faced professional sanctions. No official at the Department of Public Health who presided over the Hinton Lab's collapse of oversight was held personally accountable. Daniel Young, Dookhan's supervisor whose signature she forged, retired.

The prosecutors in the Attorney General's office who withheld Farak's notebook — who looked defense attorneys and judges in the eye and made representations about Farak's drug use history that they knew to be incomplete — did not face criminal charges. The Massachusetts Board of Bar Overseers investigated several of them. Some received admonishments. The attorneys involved continued to practice law.

Maura Healey, whose office oversaw the continued suppression of the Farak evidence and was found by the state's highest court to have committed egregious misconduct, was elected Governor of Massachusetts in November 2022 with 63 percent of the vote. Questions about her office's conduct in the Farak case received minimal attention during the campaign. She took office in January 2023.

This is what accountability looks like in Massachusetts. This is what it looks like in most places.

A National Pattern: Massachusetts Was Not an Exception

It would be comforting to treat the Massachusetts drug lab scandals as aberrations — the product of uniquely dysfunctional institutions in one state. They were not. In the years since Dookhan's arrest, forensic fraud scandals have emerged in state after state, at a frequency that suggests the problem is systemic rather than exceptional.

In North Carolina, a State Bureau of Investigation analyst named Duane Deaver was found to have overstated the significance of blood evidence in hundreds of cases, including the capital case of Greg Taylor, who spent 17 years in prison before being exonerated in 2010. In Texas, the Houston Police Department Crime Lab was found to have mishandled DNA evidence and reported erroneous results in dozens of cases. In West Virginia, state police chemist Fred Zain fabricated evidence in an estimated 134 cases over a decade spanning the 1980s and 1990s, sending innocent people to prison, including at least one man to death row. In Oklahoma, forensic analyst Joyce Gilchrist was found to have given misleading testimony and mishandled evidence in numerous cases, contributing to at least one wrongful execution.

The pattern is consistent: a forensic analyst operates with minimal supervision, produces results that serve prosecutorial interests, and goes unchallenged for years because the institutions around them have every incentive to take their results at face value. When the fraud finally emerges, the response is damage control rather than accountability. Prosecutors fight to preserve convictions. Oversight bodies move slowly. The analyst receives a fraction of the consequences they caused. And the structural conditions that made the fraud possible remain largely unchanged.

The 2009 National Academy of Sciences report identified these structural conditions clearly and recommended sweeping reforms: independent oversight of forensic laboratories, separation of crime labs from law enforcement agencies, mandatory accreditation, blind proficiency testing, and uniform reporting standards. Fifteen years later, most of those recommendations have not been implemented on any consistent national basis.

A Blueprint for Reform: What Must Change

The Massachusetts drug lab scandal offers a clear and damning lesson about what happens when forensic science operates without accountability. Preventing the next Annie Dookhan — or, more accurately, the next dozen Annie Dookhans — requires structural reforms that go well beyond the ad hoc responses states have typically offered after these scandals emerge. Here is what must change:

1. Mandatory independence of forensic laboratories from law enforcement. Crime labs that are organizationally subordinate to police departments or prosecutorial offices face an inherent conflict of interest. They are structurally incentivized to produce results that support prosecution rather than truth. All state forensic laboratories should be administered by independent agencies, with governing boards that include representatives of defense bars and civil liberties organizations, not just law enforcement.
2. Output-based anomaly detection with automatic escalation. Annie Dookhan's fraud was detectable from her output numbers alone. Any analyst processing samples at rates significantly exceeding their peers should trigger automatic review — not a commendation. Every forensic laboratory in the country should have statistical monitoring systems that flag anomalies and require supervisory review. These systems should report to external oversight bodies, not just internal management.
3. Mandatory blind proficiency testing. Forensic analysts should regularly receive test samples — samples whose true characteristics are known to oversight bodies but not to the analyst — and their results should be recorded and reviewed. Systematic failures in proficiency testing should result in suspension and review of all prior work. Currently, proficiency testing in many jurisdictions is neither blind nor sufficiently frequent to catch fraud before it affects thousands of cases.
4. Brady obligations extended to forensic fraud. When a state becomes aware that a forensic analyst whose work contributed to convictions has been found to have engaged in misconduct, it should have an affirmative, immediate obligation to notify all defendants whose cases were affected — without waiting for those defendants to seek relief. The current model, which places the burden on defendants to discover and pursue their own claims, is inadequate and results in injustice persisting for years after fraud is discovered.
5. Criminal liability for cover-ups by state officials. The Massachusetts AG's office found by the SJC to have committed "egregious misconduct" in the Farak matter faced no criminal accountability. Prosecutors and AG officials who deliberately withhold exculpatory evidence related to forensic fraud — who make false representations to courts about the scope of misconduct — should face criminal charges for obstruction of justice. The existing legal framework permits this; what is lacking is the political will to apply it.
6. Statute of limitations reform for forensic fraud victims. Many defendants whose convictions were tainted by Dookhan and Farak were unable to seek relief because statutes of limitations on post-conviction challenges had expired. States should enact discovery rules that toll the statute of limitations until the defendant learns, or reasonably should have learned, of the fraud that affected their case.
7. Compensation for those wrongly convicted. Massachusetts, like most states, has limited mechanisms for compensating individuals whose convictions were vacated due to state misconduct. The drug lab defendants who spent time in prison on fraudulent evidence deserve more than a certificate of dismissal. They deserve meaningful compensation, including for lost wages, lost opportunities, and the collateral consequences of the convictions they carried.
8. Mandatory accreditation and audit of all forensic labs. Congress should condition federal criminal justice funding on state forensic laboratory accreditation through bodies like ASCLD (the American Society of Crime Laboratory Directors) and on compliance with NIST standards for forensic science. The carrot of federal funding has moved states on criminal justice issues before. It should be deployed here.

Conclusion: The Fraud That Accountability Forgot

Annie Dookhan is out of prison. Sonja Farak served her time and moved on. The Massachusetts AG officials who hid Farak's notebook from defense attorneys and courts — who were found by the state's highest court to have committed egregious misconduct — are still practicing law. Maura Healey is the Governor of Massachusetts.

The 40,000-plus defendants whose cases were touched by these frauds live with the consequences of what was done to them — some with vacated convictions, some still carrying records they have not yet managed to expunge, some with collateral consequences that no court order can undo. The families who were separated. The jobs that were lost. The opportunities that closed. The years that cannot be recovered.

The Massachusetts drug lab scandal should be a case study taught in every law school in the country. It should be the subject of a federal investigation into forensic oversight failures. It should have ended careers and prompted sweeping national reform. Instead, it faded from the headlines after a few years, the structural problems it revealed went largely unaddressed, and the officials responsible for the worst of the cover-up went on to higher office.

This is the story of American justice in the twenty-first century: fraud on an industrial scale, accountability calibrated to protect the powerful, and victims left to find their own way through a system that failed them once and then abandoned them entirely. The Founders built a republic premised on the idea that government derives its legitimacy from justice, not merely power. By that standard, Massachusetts — and the many states whose forensic oversight failures mirror it — has some reckoning still to do.